Nivolumab plus relatlimab and nivolumab plus ipilimumab for patients with advanced renal cell carcinoma: results from the open-label, randomised, phase II FRACTION-RCC trial von Choueiri, T.K., Kuzel, T.M., Tykodi, S.S., Verzoni, E., Kluger, H., Nair, S., Perets, R., George, S., Gurney, H., Pachynski, R.K., Folefac, E., Castonguay, V., Lee, C.-H., Vaishampayan, U., Miller, W.H., Bhagavatheeswaran, P., Wang, Y., Gupta, S., DeSilva, H., Lee, C.-W., Escudier, B., Motzer, R.J.

Volltext

The PML/RARα Oncoprotein Is a Direct Molecular Target of Retinoic Acid in Acute Promyelocytic Leukemia Cells von Raelson, John V., Nervi, Clara, Rosenauer, Angelika, Benedetti, Laura, Monczak, Yury, Pearson, Mark, Pelicci, Pier Giuseppe, Miller, Wilson H.

Volltext

Role of the histone deacetylase complex in acute promyelocytic leukaemia von Evans, Ronald M, Lin, Richard J, Nagy, Laszlo, Inoue, Satoshi, Shao, Wenlin, Miller, Wilson H

Volltext

A review of cancer immunotherapy: from the past, to the present, to the future von Esfahani, K, Roudaia, L, Buhlaiga, N, Del Rincon, S V, Papneja, N, Miller, Jr, W H

Volltext

Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-α fusion mRNA von MILLER, W. H, LEVINE, K, DEBLASIO, A, FRANKEL, S. R, DMITROVSKY, E, WARRELL, R. P

Volltext

Reverse Transcription Polymerase Chain Reaction for the Rearranged Retinoic Acid Receptor α Clarifies Diagnosis and Detects Minimal Residual Disease in Acute Promyelocytic Leukemia... von Miller, Wilson H., Kakizuka, Akira, Frankel, Stanley R., Warrell, Raymond P., DeBlasio, Anthony, Levine, Kristi, Evans, Ronald M., Dmitrovsky, Ethan

Volltext

Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study von Maio, M., Ascierto, P.A., Manzyuk, L., Motola-Kuba, D., Penel, N., Cassier, P.A., Bariani, G.M., De Jesus Acosta, A., Doi, T., Longo, F., Miller, W.H., Oh, D.-Y., Gottfried, M., Xu, L., Jin, F., Norwood, K., Marabelle, A.

Volltext

Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors von Hellmann, M.D., Kim, T.-W., Lee, C.B., Goh, B.-C., Miller, W.H., Oh, D.-Y., Jamal, R., Chee, C.-E., Chow, L.Q.M., Gainor, J.F., Desai, J., Solomon, B.J., Das Thakur, M., Pitcher, B., Foster, P., Hernandez, G., Wongchenko, M.J., Cha, E., Bang, Y.-J., Siu, L.L., Bendell, J.

Volltext

A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer von Aglietta, M., Barone, C., Sawyer, M.B., Moore, M.J., Miller, W.H., Bagalà, C., Colombi, F., Cagnazzo, C., Gioeni, L., Wang, E., Huang, B., Fly, K.D., Leone, F.

Volltext

A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein von Dyck, Jacqueline A., Maul, Gerd G., Miller, Wilson H., Chen, J.Don, Kakizuka, Akira, Evans, Ronald M.

Volltext

Phase I clinical trial of i.v. ascorbic acid in advanced malignancy von Hoffer, L.J., Levine, M., Assouline, S., Melnychuk, D., Padayatty, S.J., Rosadiuk, K., Rousseau, C., Robitaille, L., Miller, W.H.

Volltext

Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML von Kakizuka, A., Miller, W.H., Umesono, K., Warrell, R.P., Frankel, S.R., Murty, V.V.V.S., Dmitrovsky, E., Evans, R.M.

Volltext

Early Mortality and the Retinoic Acid Syndrome in Acute Promyelocytic Leukemia: Impact of Leukocytosis, Low-Dose Chemotherapy, PMN/RAR-α Isoform, and CD13 Expression in Patients Tr... von Vahdat, Linda, Maslak, Peter, Miller, Wilson H., Eardley, Anna, Heller, Glenn, Scheinberg, David A., Warrell, Raymond P.

Volltext

Clinical and Molecular Characterization of a Rare Syndrome of Acute Promyelocytic Leukemia Associated With Translocation (11; 17) von Licht, Jonathan D., Chomienne, Christine, Goy, Andre, Chen, Alex, Scott, Amy A., Head, David R., Michaux, Jean Louis, Wu, Yu, DeBlasio, Anthony, Miller, Wilson H., Zelenetz, Andrew D., Willman, Cheryl L., Chen, Zhu, Chen, Sai-Juan, Zelent, A., Macintyre, Elizabeth, Veil, Agnes, Cortes, Jorge, Kantarjian, Hagop, Waxman, Samuel

Volltext

CONTINUOUS TREATMENT WITH ALL-TRANS RETINOIC ACID CAUSES A PROGRESSIVE REDUCTION IN PLASMA DRUG CONCENTRATIONS - IMPLICATIONS FOR RELAPSE AND RETINOID RESISTANCE IN PATIENTS WITH A... von MUINDI, J, FRANKEL, MILLER, WH, JAKUBOWSKI, A, SCHEINBERG, DA, YOUNG, CW, DMITROVSKY, E, WARRELL, RP

Volltext

Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine von Grob, J.-J., Amonkar, M.M., Martin-Algarra, S., Demidov, L.V., Goodman, V., Grotzinger, K., Haney, P., Kämpgen, E., Karaszewska, B., Mauch, C., Miller, W.H., Millward, M., Mirakhur, B., Rutkowski, P., Chiarion-Sileni, V., Swann, S., Hauschild, A.

Volltext

Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-speci... von ISRAELI, R. S, MILLER, W. H, HESTON, W. D. W, SU, S. L, POWELL, C. T, FAIR, W. R, SAMADI, D. S, HURYK, R. F, DEBLASIO, A, EDWARDS, E. T, WISE, G. J

Volltext

H3K27 Methylation: A Focal Point of Epigenetic Deregulation in Cancer von Nichol, J N, Dupéré-Richer, D, Ezponda, T, Licht, J D, Miller, Jr, W H

Volltext

Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score von Sahebjam, S, Aloyz, R, Pilavdzic, D, Brisson, M-L, Ferrario, C, Bouganim, N, Cohen, V, Miller, W H, Panasci, L C

Volltext

Pembrolizumab in Microsatellite Instability High or Mismatch Repair Deficient Cancers: Updated Analysis from the Phase 2 KEYNOTE-158 Study von Maio, M, Ascierto, P A, Manzyuk, L, Motola-Kuba, D, Penel, N, Cassier, P A, Bariani, G M, De Jesus Acosta, A, Doi, T, Longo, F, Miller, Jr, W H, Oh, D-Y, Gottfried, M, Xu, L, Jin, F, Norwood, K, Marabelle, A

Volltext